PEO-like plasma polymerized tetraglyme surface interactions with leukocytes and proteins: in vitro and in vivo studies.
Polyethylene oxide (PEO) surfaces reduce non-specific protein and cell interactions with implanted biomaterials and may improve their biocompatibility. PEO-like polymerized tetraglyme surfaces were made by glow discharge plasma deposition onto fluorinated ethylene propylene copolymer (FEP) substrates and were shown to adsorb less than 10 ng/cm2 of fibrinogen in vitro. The ability of the polymerized tetraglyme surfaces to resist leukocyte adhesion was studied in vitro and in vivo. Polymerized tetraglyme and FEP were implanted subcutaneously in mice and removed after 1 day or 4 weeks. Histological analysis showed a similar degree of fibrous encapsulation around all of the 4-week implants. Darkly stained wells were present in the fibrous tissues at the tissue-material interface of both FEP and tetraglyme. Scanning electron micrographs showed that in vivo macrophage adhesion to polymerized tetraglyme was much higher than to FEP. After 2-hour contact with heparinized whole blood, polymorphonuclear leukocyte (PMN) adhesion to polymerized tetraglyme was much higher than to FEP, while platelet adhesion to polymerized tetraglyme was lower than to FEP. When PMNs isolated from blood were suspended in 10% autologous plasma, cell adhesion to polymerized tetraglyme was higher than to FEP; however when the cells were suspended in heat inactivated serum, cell adhesion to FEP was higher than to polymerized tetraglyme. The surface chemistry of polymerized tetraglyme did not change after 2-hour blood contact, but displayed nitrogen functional groups after 1-day implantation and became slightly degraded after 4-week implantation. The surface chemistry of FEP did not change significantly after blood contact or implantation. Loosely bound proteins such as fibrinogen on polymerized tetraglyme may contribute to the adhesion of PMNs and macrophages and ultimately to fibrous encapsulation (the foreign body response) around the implants.
Shen
Mingchao
M
Department of Bioengineering, University of Washington, Seattle 98195, USA.
Martinson
Laura
L
Wagner
Matthew S
MS
Castner
David G
DG
Ratner
Buddy D
BD
Horbett
Thomas A
TA
D000327:Adsorption; D000818:Animals; D001673:Biodegradation, Environmental; D001792:Blood Platelets / Q000166:cytology; D002448:Cell Adhesion; D005026:Ethylene Glycols / Q000138:chemical synthesis*; D016326:Extracellular Matrix Proteins / Q000378:metabolism*; D005340:Fibrinogen / Q000378:metabolism; D006801:Humans; D020007:Implants, Experimental / Q000592:standards*; D007962:Leukocytes / Q000166:cytology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D010586:Phagocytes / Q000166:cytology; D011092:Polyethylene Glycols / Q000737:chemistry; D011138:Polytetrafluoroethylene / Q000031:analogs & derivatives* / Q000737:chemistry; D018629:Spectrometry, Mass, Secondary Ion; D013499:Surface Properties; D005465:Fluorocarbon Polymers
D005026:Ethylene Glycols; D016326:Extracellular Matrix Proteins; D005340:Fibrinogen; D011092:Polyethylene Glycols; D011138:Polytetrafluoroethylene; C096305:fluorinated ethylene propylene; D005465:Fluorocarbon Polymers; C441631:tetraglyme